What We Do We are focused on creating precision radiopharmaceutical therapies (RPTs) that transform people’s lives.
Arvind Kush · Executive Officer · decision-maker
Aubrey Haddach · Executive Officer · decision-maker
Deborah Charych · Executive Officer · decision-maker
Ken Song · Executive Officer, Director · decision-maker
Careers mailbox is known
Aug 25, 2022
Raised a round Venture round $167.9M · SEC Form D
Oct 12, 2021
Board appointment RayzeBio Appoints Mary Tagliaferri, M.D. to its Board of Directors and Expands Leadership Team with Rozalyn Littler as VP of Regulatory and Quality · businesswire
2020
Founded
Claris Bio is dedicated to advancing transformative therapies for sight-threatening conditions where limited or no treatment options exist.
No named decision-maker yet.
No careers mailbox known
In a universe of possibilities, WE SEE THINGS DIFFERENTLY WE […].
No named decision-maker yet.
Careers mailbox is known
Synlogic is the leading company advancing therapeutics based on synthetic biology, working at the intersection of biology and engineering to treat disease.
No named decision-maker yet.
Careers mailbox is known
Gene therapy for advanced coronary artery disease. XyloCor Therapeutics is focused on improving the lives of patients through our commitment to advancing novel therapies for coronary artery disease.
No named decision-maker yet.
Careers mailbox is known
Dapatkan sensasi taruhan paling transparan di ALEXISTOGEL, wujud nyata bandar toto Macau 4D 5D resmi terlengkap se-Asia dengan siaran live draw tercepat tanpa manipulasi.
Thomas Meyer · Executive Officer, Director · decision-maker
Andrea Braun · Executive Officer · decision-maker
Hernan Levett · Executive Officer · decision-maker
Calvin Roberts · Director
No careers mailbox known
Jan 26, 2018
Raised a round Venture round $5.5M · SEC Form D
Coultreon Biopharma is a clinical-stage biotech company developing next-generation precision medicines for immunology and autoimmune disease. Our pipeline targets SIK3 to deliver transformative therapies where unmet need remains high.
Pierre Raboisson · Directors · decision-maker
Careers mailbox is known
Engineering the next generation of RNAi therapeutics.
No named decision-maker yet.
Careers mailbox is known
Sep 28
Posted a role Senior Director, Assistant Corporate Controller
Sep 26
Posted 4 roles Join the RNAi revolution!, Vice President, Biometrics
5 open
$251k stated pay, 3 roles
truth B 75 100% stale
Developing novel treatments for patients with atrial fibrillation. We are developing drugs designed to safety, effectively, and quickly get patients back to where they belong - in normal sinus rhythm.
Miller Samantha · Executive Officer · decision-maker
Grace Colon · Executive Officer, Director · decision-maker
Rangachari Narasimhan · Executive Officer, Director · decision-maker
Dan Welch · Director
Careers mailbox is known
Oct 6, 2020
Raised a round Venture round $28M · SEC Form D
